Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.
02:00am, Wednesday, 26'th Apr 2023
Hart-Scott- Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc. Paris, France – April 26 , 2023 – Sanofi announced today that the waiting period under the Hart-Scott-Rod
The 5 Best- and Worst-Performing Mid-Cap Stocks in March 2023
10:58pm, Monday, 10'th Apr 2023
March was a good month for the stock market, with the S&P 500 gaining about 3.5%.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Provention B
Why Provention Bio Stock Skyrocketed 256% This Week
04:56pm, Thursday, 16'th Mar 2023
Sanofi plans to acquire Provention Bio for around $2.9 billion. The deal will add Provention's type 1 diabetes drug Tzield to Sanofi's lineup.
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
01:44pm, Tuesday, 14'th Mar 2023
Provention Bio (PRVB) to be acquired by pharma-giant Sanofi (SNY) for $2.9 billion. The transaction is likely to close by second-quarter 2023.
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Provention Bio, Inc. - PRVB
03:32am, Tuesday, 14'th Mar 2023
NEW YORK , March 14, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm
This biopharma stock jumped over 250% on Monday: what happened?
08:22pm, Monday, 13'th Mar 2023
Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the biopharmaceutical company that focused on autoimmune diseases.
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
07:15pm, Monday, 13'th Mar 2023
Markets were mixed on a volatile day on Wall Street. Sanofi offered to buy Provention Bio at a price more than triple where the stock closed Friday.
Shareholder Alert: Ademi LLP investigates whether Provention Bio, Inc. has obtained a Fair Price in its transaction with Sanofi
12:42pm, Monday, 13'th Mar 2023
MILWAUKEE , March 13, 2023 /PRNewswire/ -- Ademi LLP is investigating Provention Bio (Nasdaq: PRVB) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi.
Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio
11:17am, Monday, 13'th Mar 2023
Here are some of the biggest movers on Monday with banks firmly in focus after federal regulators stepped into protect deposits at fallen bank SVB.
Provention Bio shares soar after Sanofi agrees to buy company in $2.9B cash deal
10:15am, Monday, 13'th Mar 2023
French drugmaker Sanofi has announced an agreement to acquire US-based biopharmaceutical company Provention Bio Inc (NASDAQ:PRVB), which focuses on autoimmune diseases, for $25 per share in cash, or
PRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholders
09:17am, Monday, 13'th Mar 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Provention Bio, Inc. (NASDAQ: PRVB) to Sanofi for $25.00 per share in cash is fair to Pro
Why Is Provention Bio (PRVB) Stock Up 263% Today?
08:13am, Monday, 13'th Mar 2023
Provention Bio (NASDAQ: PRVB ) stock is rocketing higher on Monday following news that Sanofi (NASDAQ: SNY ) is acquiring the company. That deal has Sanofi agreeing to acquire Provention Bio for $2
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
07:00am, Monday, 13'th Mar 2023
RED BANK, N.J. , March 13, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced it ha
Sanofi To Buy Provention Bio In $2.9 Billion Deal (SNY) (PRVB)
06:43am, Monday, 13'th Mar 2023
Sanofi (NASDAQ: SNY) announced it is buying Provention Bio (NASDAQ: PRVB) as part of a $2.9 billion deal. These are the details.
